hematologic malignancies
Aussie Variant Classification Effort Aims to Reduce Uncertainty in Hereditary Blood Cancer Diagnosis
Premium
The researchers hope to determine whether tens of thousands of variants in RUNX1 and GATA2 increase predisposition to blood cancers.
MD Anderson Cancer Center researchers demonstrated the prognostication utility of optical genome mapping in myelodysplastic syndromes patients.
Allogeneic Stem Cell Transplant Outcomes Improve With Diverse Gut Microbes, Immune Cells
By profiling the gut microbiome and blood immune cells, researchers found features linked to good outcomes and lower graft-versus-host disease rates.
Owkin, ADC Therapeutics Team on AI-Based Biomarker Discovery
The Paris-based bioinformatics firm will help ADC Therapeutics identify novel biomarkers for treating hematologic cancers.
Thermo Fisher Scientific Obtains CE Mark for Ion Torrent Genexus Dx Integrated Sequencer
The company is developing a sample-to-report diagnostic workflow and a portfolio of clinically validated assays for the sequencing platform.